申请人:Martin Barrie
公开号:US20080207596A1
公开(公告)日:2008-08-28
The invention concerns a compound of formula (I)
or pharmaceutically-acceptable salts thereof wherein R
1
, R
2
, R
3
, R
4
, R
5
and m are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of diseases or medical conditions mediated by cytokines.
本发明涉及式(I)的化合物或其药学上可接受的盐,其中R1、R2、R3、R4、R5和m如规范中所定义,其制备过程,包含它们的制药组合物以及它们在治疗由细胞因子介导的疾病或医疗条件中的用途。